Clinical results of N-acetylcysteine after major hepatic surgery: A review

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 15, Issue 5, 2008, Pages 473-478

  McKay, Andrew ^a   Cassidy, Darby ^a   Sutherland, Francis ^a   Dixon, Elijah ^a  

^a TOM BAKER CANCER CENTRE   (Canada)

Author keywords

Ischemia Reperfusion; Liver; N acetylcysteine; Review; Surgery

Indexed keywords

ACETYLCYSTEINE; AMINO ACID; AMINOTRANSFERASE; GLUTATHIONE TRANSFERASE ALPHA; INTERCELLULAR ADHESION MOLECULE 1; PLACEBO; UREA; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE GRAFT REJECTION; AMINOTRANSFERASE BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; BILE FLOW; CLINICAL TRIAL; DRUG MECHANISM; HEART INDEX; HUMAN; LIVER BLOOD FLOW; LIVER DYSFUNCTION; LIVER GRAFT REJECTION; LIVER INJURY; LIVER ISCHEMIA; LIVER METABOLISM; LIVER SURGERY; LIVER TRANSPLANTATION; MAJOR SURGERY; MEDLINE; MICROCIRCULATION; NONHUMAN; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROTEIN METABOLISM; REPERFUSION INJURY; REVIEW; TREATMENT RESPONSE;

ACETYLCYSTEINE; GASTROINTESTINAL AGENTS; HEPATECTOMY; HUMANS; REPERFUSION INJURY;

EID: 53549134712     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-007-1306-6     Document Type: Review

References (35)

1. Abdalla EK, Noun R, Belghiti J. Hepatic vascular occlusion: Which technique? Surg Clin North Am 2004;84:563-585.
2. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, et al. Continuous versus intermittent portal triad clamping for liver resection: A controlled study. Ann Surg 1999;229:369-375.
3. Fan ST. Protection of the liver during partial hepatectomy. Hepatobiliary Pancreat Dis Int 2004;3:490-494.
4. Takeda K, Togo S, Kunihiro O, Fujii Y, Kurosawa H, Tanaka K, et al. Clinicohistological features of liver failure after excessive hepatectomy. Hepatogastroenterology 2002;49:354-358.
5. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292-298.
6. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-163.
7. Hammond CL, Lee TK, Ballatori N. Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. J Hepatol 2001;34:946-954.
8. Ross D. Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. Pharmacol Ther 1988;37:231-249.
9. Vreugdenhil PK, Belzer FO, Southard JH. Effect of cold storage on tissue and cellular glutathione. Cryobiology 1991;28:143-149.
10. Fukuzawa K, Emre S, Senyuz O, Acarli K, Schwartz ME, Miller CM. N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation 1995;59:6-9.
11. Demir S, Inal-Erden M. Pentoxifylline and N-acetylcysteine in hepatic ischemia/reperfusion injury. Clin Chim Acta 1998;275:127-135.
12. De Flora S, Bennicelli C, Camoirano A, Serra D, Romano M, Rossi GA, et al. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds. Carcinogenesis 1985;6:1735-1745.
13. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989;6:593-597.
14. Kharazmi A, Nielsen H, Schiotz PO. N-Acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism. Int J Immunopharmacol 1988;10:39-46.
15. Majano PL, Medina J, Zubia I, Sunyer L, Lara-Pezzi E, Maldonado-Rodriguez A, et al. N-Acetyl-cysteine modulates inducible nitric oxide synthase gene expression in human hepatocytes. J Hepatol 2004;40:632-637.
16. Koo A, Komatsu H, Tao G, Inoue M, Guth PH, Kaplowitz N. Contribution of no-reflow phenomenon to hepatic injury after ischemia-reperfusion: evidence for a role for superoxide anion. Hepatology 1992;15:507-514.
17. Devlin J, Ellis AE, McPeake J, Heaton N, Wendon JA, Williams R. N-Acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med 1997;25:236-242.
18. Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, et al. N-Acetylcysteine increases liver blood flow and improves liver function in septic shock patients: Results of a prospective, randomized, double-blind study. Crit Care Med 2000;28:3799-3807.
19. Bromley PN, Cottam SJ, Hilmi I, Tan KC, Heaton N, Ginsburg R, et al. Effects of intraoperative N-acetylcysteine in orthotopic liver transplantation. Br J Anaesth 1995;75:352-354.
20. Regueira FM, Cienfuegos JA, Pardo F, Hernandez JL, ez-Caballero A, Sierra A, et al. Improvement in early function of the hepatic graft after treatment of the donor with N-acetylcysteine: Clinical study. Transplant Proc 1997;29:3350-3352.
21. Thies JC, Teklote J, Clauer U, Tox U, Klar E, Hofmann WJ, et al. The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation. Transpl Int 1998;11(Suppl 1):S390-S392.
22. Weigand MA, Plachky J, Thies JC, Spies-Martin D, Otto G, Martin E, et al. N-Acetylcysteine attenuates the increase in alpha-glutathione S-transferase and circulating ICAM-1 and VCAM-1 after reperfusion in humans undergoing liver transplantation. Transplantation 2001;72:694-698.
23. Steib A, Freys G, Collin F, Launoy A, Mark G, Boudjema K. Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation? Liver Transpl Surg 1998;4:152-157.
24. Oellerich M, Burdelski M, Lautz HU, Rodeck B, Duewel J, Schulz M, et al. Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation 1991;51:801-806.
25. Khan AW, Fuller BJ, Shah SR, Davidson BR, Rolles K. A prospective randomized trial of N-acetyl cysteine administration during cold preservation of the donor liver for transplantation. Ann Hepatol 2005;4:121-126.
26. Taut FJ, Breitkreutz R, Zapletal CM, Thies JC, Babylon A, Martin E, et al. Influence of N-acetylcysteine on hepatic amino acid metabolism in patients undergoing orthotopic liver transplantation. Transpl Int 2001;14:329-333.
27. Okay E, Karadenizli A, Muezzinoglu B, Zeybek U, Arzu EH, Isbir T. N-Acetylcysteine attenuates bacterial translocation after partial hepatectomy in rats. J Surg Res 2005;127:164-170.
28. Glantzounis GK, Rocks SA, Sheth H, Knight I, Salacinski HJ, Davidson BR, et al. Formation and role of plasma S-nitrosothiols in liver ischemia-reperfusion injury. Free Radic Biol Med 2007 15;42:882-892.
29. Chen CF, Leu FJ, Chen HI, Wang D. Oxygen radicals and matrix metalloproteinases mediate reperfusion liver injury. Transplant Proc 2005;37:4547-4549.
30. Sener G, Tosun O, Sehirli AO, Kacmaz A, Arbak S, Ersoy Y, et al. Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion. Life Sci 2003;72:2707-2718.
31. Koeppel TA, Lehmann TG, Thies JC, Gehrcke R, Gebhard MM, Herfarth C, et al. Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantation. Transplantation 1996;61:1397-1402.
32. Glantzounis GK, Yang W, Koti RS, Mikhailidis DP, Seifalian AM, Davidson BR. Continuous infusion of N-acetylcysteine reduces liver warm ischaemia-reperfusion injury. Br J Surg 2004;91:1330-1339.
33. Regueira FM, Hernandez JL, Sola I, Cienfuegos JA, Pardo F, ez-Caballero A, et al. Ischemic damage prevention by N-acetylcysteine treatment of the donor before orthotopic liver transplantation. Transplant Proc 1997;29:3347-3349.
34. Yip L, Dart RC, Hurlbut KM. Intravenous administration of oral N-acetylcysteine. Crit Care Med 1998;26:40-43.
35. Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998;31:710-715.